No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr9:21965400-21972000 |
Weak transcription |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
2 |
chr9:21966200-21971000 |
Bivalent Enhancer |
ES-UCSF4 Cell Line |
embryonic stem cell
|
3 |
chr9:21966200-21972000 |
Strong transcription |
Dnd41 |
blood
|
4 |
chr9:21967200-21971200 |
ZNF genes & repeats |
HMEC |
breast
|
5 |
chr9:21968200-21971400 |
Bivalent Enhancer |
Fetal Muscle Trunk |
muscle
|
6 |
chr9:21968400-21971200 |
ZNF genes & repeats |
HSMM |
muscle
|
7 |
chr9:21968800-21971000 |
Bivalent Enhancer |
H1 Cell Line |
embryonic stem cell
|
8 |
chr9:21968800-21971200 |
ZNF genes & repeats |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
9 |
chr9:21969000-21971600 |
Bivalent Enhancer |
Cortex derived primary cultured neurospheres |
brain
|
10 |
chr9:21970000-21971000 |
ZNF genes & repeats |
GM12878-XiMat |
blood
|
11 |
chr9:21970000-21971200 |
ZNF genes & repeats |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
12 |
chr9:21970200-21971400 |
ZNF genes & repeats |
Lung |
lung
|
13 |
chr9:21970200-21971400 |
Bivalent Enhancer |
Placenta Amnion |
Placenta Amnion
|
14 |
chr9:21970400-21971000 |
Bivalent Enhancer |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
15 |
chr9:21970400-21971000 |
Bivalent Enhancer |
hESC Derived CD56+ Ectoderm Cultured Cells |
ES cell derived
|
16 |
chr9:21970400-21971000 |
Flanking Bivalent TSS/Enh |
HUES6 Cell Line |
embryonic stem cell
|
17 |
chr9:21970400-21971400 |
Bivalent/Poised TSS |
iPS-15b Cell Line |
embryonic stem cell
|
18 |
chr9:21970400-21971400 |
Bivalent Enhancer |
Primary monocytes fromperipheralblood |
blood
|
19 |
chr9:21970600-21971000 |
Flanking Bivalent TSS/Enh |
iPS-18 Cell Line |
embryonic stem cell
|
20 |
chr9:21970600-21971000 |
Bivalent Enhancer |
Foreskin Melanocyte Primary Cells skin03 |
Skin
|
21 |
chr9:21970600-21971200 |
Bivalent/Poised TSS |
HUES64 Cell Line |
embryonic stem cell
|
22 |
chr9:21970600-21971200 |
Flanking Bivalent TSS/Enh |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
23 |
chr9:21970600-21971200 |
Bivalent Enhancer |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
24 |
chr9:21970600-21971200 |
Bivalent Enhancer |
Stomach Smooth Muscle |
stomach
|
25 |
chr9:21970600-21971400 |
Bivalent/Poised TSS |
ES-I3 Cell Line |
embryonic stem cell
|
26 |
chr9:21970600-21971400 |
Flanking Bivalent TSS/Enh |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
27 |
chr9:21970600-21971400 |
Bivalent Enhancer |
HUVEC |
blood vessel
|
28 |
chr9:21970600-21971600 |
Bivalent Enhancer |
Primary T cells fromperipheralblood |
blood
|
29 |
chr9:21970800-21971000 |
Bivalent Enhancer |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
30 |
chr9:21970800-21971000 |
Bivalent Enhancer |
Brain Substantia Nigra |
brain
|
31 |
chr9:21970800-21971000 |
Bivalent Enhancer |
Duodenum Mucosa |
Duodenum
|
32 |
chr9:21970800-21971000 |
Flanking Bivalent TSS/Enh |
Spleen |
Spleen
|
33 |
chr9:21970800-21971200 |
Bivalent Enhancer |
ES-WA7 Cell Line |
embryonic stem cell
|
34 |
chr9:21970800-21971200 |
Bivalent/Poised TSS |
HUES48 Cell Line |
embryonic stem cell
|
35 |
chr9:21970800-21971200 |
Flanking Bivalent TSS/Enh |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
36 |
chr9:21970800-21971200 |
Bivalent Enhancer |
Fetal Brain Male |
brain
|
37 |
chr9:21970800-21971200 |
Bivalent Enhancer |
Gastric |
stomach
|
38 |
chr9:21970800-21971200 |
Bivalent Enhancer |
Right Ventricle |
heart
|
39 |
chr9:21970800-21971400 |
Bivalent/Poised TSS |
iPS-20b Cell Line |
embryonic stem cell
|
40 |
chr9:21970800-21971400 |
Flanking Bivalent TSS/Enh |
Foreskin Melanocyte Primary Cells skin01 |
Skin
|
41 |
chr9:21970800-21971600 |
Bivalent Enhancer |
Fetal Heart |
heart
|
42 |
chr9:21970800-21971800 |
Strong transcription |
Hela-S3 |
cervix
|
43 |
chr9:21970800-21972200 |
Weak transcription |
HSMMtube |
muscle
|